The purpose of the notification is to produce chitosan gels, formed at human body temperature, intended for injection moulds for the production of nerve cells, which consist of the introduction into the temperature -cooled 4 -degree aqueous solution of acetate, chlorine, lactate chitosan, composed of chitosan with deacetylation rate above 70% and molecular weight 500 -700 kDa, also chilled to the temperature 4%C of the disodium disodium 5'-monophosphate solution of uridine,mixing of constituents and reacting at a temperature of four degrees in the 24 -hour time of the sulphur formed in the form of gel at the temperature of the human body. Measures to assist nerve regeneration, such as cobalamine, lipoic acid, graphene oxide, are also introduced into the solution of chitosan salt, prior to the introduction of the solution of uridine 5'-monophosphate.
